生命科学资讯

Grail stock craters as key NHS-Galleri cancer blood test trial fails to hit primary endpoint

Mainz Biomed looks to shed ColoAlert, shifts focus in US

Chutes & Ladders—Roche taps Aussie oncologist to lead early research

Biohaven charts comeback path after FDA blow, placing bets on obesity

Candel glows brighter with $100M RTW royalty deal to fund prostate cancer drug's launch

Daiichi picks former Novartis CMO John Tsai to head up R&D

White House frustration may have fueled FDA’s Moderna walkback: Politico

Novartis winds down ph. 1 solid tumor program after lacking efficacy

Sanofi backs Altesa's $75M series B to bankroll antiviral's midstage rhinovirus study

Study finds blood test can predict age of Alzheimer's onset

J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy

GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research

NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports

Senate HELP Committee chair pitches proposals for FDA reform

Blood from pediatricians yields potential new medicines for respiratory viruses

FDA accepts filing for Moderna flu vaccine after swift rethink

Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal

Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug